Volume 27, Issue 123 (July & August 2019)                   J Adv Med Biomed Res 2019, 27(123): 16-22 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azadbakht M, Ahmadi S A, Ahangar N. Antidiabetic Activity of Aqueous Seed Extract of Securigera securidaca in Streptozotocin Induced Diabetic Rats. J Adv Med Biomed Res 2019; 27 (123) :16-22
URL: http://journal.zums.ac.ir/article-1-5522-en.html
Antidiabetic Activity of Aqueous Seed Extract of Securigera securidaca in Streptozotocin Induced Diabetic Rats
Mohammad Azadbakht1 , Seyyedeh Atiyeh Ahmadi2 , Nematollah Ahangar *3
1- Dept. of Pharmacognosy& Biotechnology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
2- Student Researches Committee, Ramsar Campus, Mazandaran University of Medical Sciences, Ramsar, Iran
3- Dept. of Pharmacology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran , dr.n.ahangar@gmail.com
Abstract:   (147544 Views)

Background & Objective: Securigera securidaca is a medicinal plant used in Persian folk medicine to decrease blood sugar. Nevertheless, there is some controversy about its effects. The current study investigated the hypoglycemic activity of the aqueous seed extract of S. securidaca.
Materials & Methods: Sixty mature male Charles-River rats were categorized and divided randomly into 10 groups with two timeframes (7 and 14 days). To induce diabetes, rats were injected intraperitoneally with 7 mg/0.5 mL streptozotocin in normal saline per 100 g body weight. The aqueous seed extract of S. securidaca was given orally to rats daily (80 mg/0.5 mL in distilled water per 100 g of rat body weight). The blood sugar of rats was measured on the 7th and 14th days. Blood lipid indices and ALT, AST, and ALP plasma levels were measured after 14 days of treatment.
Results: The findings showed that the S. securidaca aqueous seed extract had a significant effect on the blood sugar of rats after 7 and 14 days compared with the diabetic group. After 14 days, there was a significant difference in the weight of treated rats between the S. securidaca aqueous seed extract and diabetic groups. The S. securidaca aqueous seed extract had no significant effect on the blood lipid profiles of the treated rats. The AST enzyme levels were significantly higher in rats exposed to the seed extract than in the diabetic group. 
Conclusion: Based on the results, S. securidaca seed extract had a significant effect in reducing the blood sugar of diabetic rats with no significant changes in lipid profiles. More studies are needed to explore in more detail the mechanism of this hypoglycemic effect.

Keywords: Diabetes, Rat, Securigera securidaca, Streptozotocin
Full-Text [PDF 602 kb]   (156117 Downloads) |   |   Full-Text (HTML)  (2772 Views)  

✅ Based on the results, S. securidaca seed extract had a significant effect in reducing the blood sugar of diabetic rats with no significant changes in lipid profiles. More studies are needed to explore in more detail the mechanism of this hypoglycemic effect.


Type of Study: Original Research Article | Subject: Medical Laboratory and Animal Investigation
Received: 2019/01/22 | Accepted: 2019/03/1 | Published: 2019/07/1
References
1. Panjeshahin MR, Azadbakht M, Akbari N. Antidiabetic activity of different extracts of Myrtus communis in streptozotocin induced diabetic rats. Rom J Diabetes Nutr Metab Dis. 2016;23(2):183-90. [DOI:10.1515/rjdnmd-2016-0022] [DOI:10.1515/rjdnmd-2016-0022]
2. Azadbakht M, Safapour S, Ahmadi A, Ghasemi M, Shokrzadeh M. Anti-diabetic effects of aqueous fruits extract of Diospyros lotus L. on streptozotocin-induced diabetic rats and the possible morphologic changes in the liver, kidney and heart. J Pharmacogn Phytochem. 2010; 2(2): 10-16.
3. Arumugam G, Manjula P, Paari N. A review: Anti diabetic medicinal plants used for diabetes mellitus. J Acute Dis. 2013; 2(3): 196-200. [DOI:10.1016/S2221-6189(13)60126-2] [DOI:10.1016/S2221-6189(13)60126-2]
4. Federation ID. IDF diabetes atlas. Brussels: International Diabetes Federation. 2013.
5. Li S, Guo S, He F, et al. Prevalence of diabetes mellitus and impaired fasting glucose, associated with risk factors in rural Kazakh adults in Xinjiang, China. Int J Environ Res Public Health. 2015; 12(1): 554-65. [DOI:10.3390/ijerph120100554] [DOI:10.3390/ijerph120100554] [PMID] [PMCID]
6. Alavinia M, Ghotbi M, Mahdavi Hezave A, Kermanchi J, Nasli Esfahani A, Yarahmadi S. National program for prevention and control of diabetes type II: Implementation in urban areas. Tehran. Sepidbarg. 2012: 12-8.
7. Zahedi-Asl S, Marahel H, Zaree B. Study on the effects of chloroformic extract of Securigera Securidaca on serum glucose level and liver glycogen content of mice.J Kerman Univ Med Sci. 2005;11(1):32-8.
8. Andrade-Cetto A, Martínez-Zurita E, Wiedenfeld H. Hypoglycemic effect of Malmea depressa root on streptozotocin diabetic rats. J Ethnopharmacol. 2005; 100(3): 319-22. [DOI:10.1016/j.jep.2005.03.021] [DOI:10.1016/j.jep.2005.03.021] [PMID]
9. Minaiyana M, Moattar F, Vali A. Effect of Securigera securidaca seeds on blood glucose level of normal and diabetic rats. Iran J Pharm Res. 2006; 2(3): 151-6.
10. Hosseinzadeh H, Ramezani M, Danaei A. Antihyperglycaemic effect and acute toxicity of Securigera Securidaca L. seed extracts in mice. Phytother Res. 2002; 16(8): 745-7. [DOI:10.1002/ptr.1020] [DOI:10.1002/ptr.1020] [PMID]
11. Ghahreman A, Okhovvat AR. Matching the old medicinal plant names with scientific terminology. Tehran Univ Press. 2010.
12. Ghahreman A. Cormophytes of Iran (plant systematics). Tehran Univ Press. 1999.
13. Ibrahim RM, El-Halawany AM, Saleh DO, El Naggar EMB, El-Shabrawy AE-RO, El-Hawary SS. HPLC-DAD-MS/MS profiling of phenolics from Securigera securidaca flowers and its anti-hyperglycemic and anti-hyperlipidemic activities. Rev Bras Farmacogn. 2015; 25(2): 134-41. [DOI:10.1016/j.bjp.2015.02.008] [DOI:10.1016/j.bjp.2015.02.008]
14. Rajaei Z, Mousa-Al-Reza Hadjzadeh RM, Ghorbani A, Saghebi A. Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Securigera securidaca seeds in streptozotocin-induced diabetic rats. Adv Biomed Res. 2015; 4: 33. [DOI:10.4103/2277-9175.150427] [DOI:10.4103/2277-9175.150427] [PMID] [PMCID]
15. Moitra SK, Ganguly AN, Chakravarti NN, Adhya RN. Chemical investigation of the constituents of the seeds of Securigera securidaca Linn. Bull Calcutta Sch Trop Med. 1969; 17(3):80-81.
16. Tofighi Z, Moradi-Afrapoli F, Ebrahimi SN, et al. Securigenin glycosides as hypoglycemic principles of Securigera securidaca seeds. J Nat Med. 2017; 71(1): 272-80. [DOI:10.1007/s11418-016-1060-7] [DOI:10.1007/s11418-016-1060-7] [PMID]
17. Sadat-Ebrahimi S, Hassanpoor Mir M, Amin G, Hajimehdipoor H. Identification of amino acids in Securigera securidaca, a popular medicinal herb in Iranian folk medicine.Res J Pharmacog. 2014; 1(1): 23-6.
18. Pouramir M, Shahaboddin ME, Moghadamnia A-A, Parastouei K. To study the effects of Securigera securidaca (L.) seed against alloxan-induced hyperglycemia. J Med Plants Res. 2011; 5(14): 3188-91.
19. Azarmi Y, Zakheri A, Allaf Akbari N, et al. The effect of total extract of Securigera securidaca L. seed on thoracic aorta function in nigh-fat fed rats. J Pharm Sci. 2009; 15(1): 83-92.
20. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr. 1998; 68(3): 545-51. [DOI:10.1093/ajcn/68.3.545] [DOI:10.1093/ajcn/68.3.545] [PMID]
21. Fathi Azad F, Allaf AN, Zakheri A, et al. Hypolipidemic and antioxidant effects of Securigera securidaca L. seed in high fat in fed rats. J Pharm Sci. 2010; 15(4): 293-301.
22. Fallah Hosseini H, Hooseini P, Heshmat R, et al. The clinical investigation of securigera securidaca (L.)(degen & doerfler) seeds in type II diabetic patients a randomized, double-blind, placebo-controlled study.J Med Plant. 2006; 4(20): 75-9.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb